IGM Biosciences, Inc. (IGMS)
USD 1.19
(-0.83%)
USD 1.19
(-0.83%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.13 Million | 1.06 Million | - | - | - | - |
| Cost of Revenue | 213.79 Million | 10.6 Million | 7.72 Million | 3.57 Million | 2.33 Million | 278 Thousand |
| Gross Profit | -211.66 Million | -9.53 Million | -7.72 Million | -3.57 Million | -2.33 Million | -278 Thousand |
| Operating Expenses | 265.59 Million | 229.02 Million | 165.32 Million | 83.28 Million | 44.49 Million | 22.79 Million |
| Selling, General and Administrative Expenses | 50.07 Million | 49.73 Million | 38.29 Million | 18.25 Million | 9.24 Million | 3.82 Million |
| Research and Development Expenses | 215.51 Million | 179.28 Million | 127.02 Million | 65.03 Million | 35.25 Million | 18.96 Million |
| Other Expenses | - | -181 Thousand | 159 Thousand | 1.92 Million | 1.36 Million | 80 Thousand |
| Cost and Expenses | 265.59 Million | 229.02 Million | 165.32 Million | 83.28 Million | 44.49 Million | 22.79 Million |
| Operating Income | -263.46 Million | -227.95 Million | -165.32 Million | -83.28 Million | -44.49 Million | -22.79 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 678 Thousand | -6.85 Million | -4.48 Million | -1.02 Million | -597 Thousand | 80 Thousand |
| Earnings before Tax | -245.73 Million | -221.1 Million | -165.16 Million | -81.35 Million | -43.13 Million | -22.71 Million |
| Net Income | -246.41 Million | -214.24 Million | -160.68 Million | -80.33 Million | -42.53 Million | -22.71 Million |
| Earnings Per Share Basic | -4.71 | -5.16 | -4.80 | -2.61 | -4.73 | -51.84 |
| Earnings Per Share Diluted | -4.71 | -5.16 | -4.80 | -2.61 | -4.73 | -51.84 |
| Weighted Average Shares Outstanding | 52.31 Million | 41.54 Million | 33.47 Million | 30.74 Million | 8.99 Million | 438.07 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 52.31 Million | 41.54 Million | 33.47 Million | 30.74 Million | 8.99 Million | 438.07 Thousand |
| Gross Margin | -99.37 | -8.92 | - | - | - | - |
| EBIT Margin | -118.95 | -213.24 | - | - | - | - |
| Profit Margin | -115.69 | -200.42 | - | - | - | - |
| EBITDA | -253.35 Million | -221.88 Million | -157.44 Million | -77.77 Million | -40.8 Million | -22.51 Million |
| Earnings Before Tax Margin | -123.69 | -213.24 | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.25 Million | 497 Thousand | 651 Thousand | 2.13 Million | 509 Thousand | 448 Thousand |
| Cost of Revenue | 2.27 Million | 2.17 Million | 2.18 Million | 8.27 Million | 2.25 Million | 3.51 Million |
| Gross Profit | -1.02 Million | -1.67 Million | -1.53 Million | -6.14 Million | -1.75 Million | -3.07 Million |
| Operating Expenses | 50.33 Million | 54.35 Million | 63.58 Million | 257.31 Million | 67.26 Million | 68.65 Million |
| Selling, General and Administrative Expenses | 10.64 Million | 10.53 Million | 11.58 Million | - | 12.5 Million | 12.98 Million |
| Research and Development Expenses | 39.68 Million | 43.81 Million | 52 Million | - | 54.76 Million | 55.67 Million |
| Other Expenses | -41.96 Million | - | 20 Thousand | -20 Thousand | - | - |
| Cost and Expenses | 52.61 Million | 54.35 Million | 65.76 Million | 265.59 Million | 67.26 Million | 68.65 Million |
| Operating Income | -51.35 Million | -53.85 Million | -65.11 Million | -263.46 Million | -66.76 Million | -68.2 Million |
| Interest Expense | - | - | 3.97 Million | - | - | - |
| Income Tax Expense | - | -2.17 Million | 242 Thousand | 678 Thousand | -240 Thousand | 109 Thousand |
| Earnings before Tax | -47.9 Million | -49.81 Million | -60.45 Million | -245.73 Million | -61.74 Million | -64.31 Million |
| Net Income | -47.9 Million | -49.81 Million | -60.69 Million | -246.41 Million | -61.98 Million | -64.42 Million |
| Earnings Per Share Basic | -0.79 | -0.83 | -1.01 | - | -1.04 | -1.43 |
| Earnings Per Share Diluted | -0.79 | -0.83 | -1.01 | - | -1.04 | -1.43 |
| Weighted Average Shares Outstanding | 60.43 Million | 60.11 Million | 59.82 Million | 52.31 Million | 59.58 Million | 45.12 Million |
| Weighted Average Shares Outstanding (Diluted) | 60.43 Million | 60.11 Million | 59.82 Million | 52.31 Million | 59.58 Million | 45.12 Million |
| Gross Margin | -0.81 | -3.38 | -2.35 | -2.89 | -3.44 | -6.85 |
| EBIT Margin | -39.14 | -108.36 | -96.68 | - | -131.16 | -147.40 |
| Profit Margin | -38.20 | -100.23 | -93.23 | -115.69 | -121.79 | -143.80 |
| EBITDA | -49.08 Million | -53.85 Million | -62.93 Million | - | -66.76 Million | -66.03 Million |
| Earnings Before Tax Margin | -40.95 | -108.36 | -100.03 | -123.69 | -131.16 | -152.25 |
OCT
SBP
3V64
PFBN
RAE
3139